sunvozertinib
dizal pharmaceuticals
['sunvozertinib', 'lung']
sunvozertinib, a selective egfr inhibitor for previously treated non small cell lung cancer with egfr exon 20 insertion mutations #asco23 #asco2023 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News